# Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole

> **NCT06318104** · PHASE4 · UNKNOWN · sponsor: **Hospital General de México Dr. Eduardo Liceaga** · enrollment: 160 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** Esomeprazole 40mg

## Key facts

- **NCT ID:** NCT06318104
- **Lead sponsor:** Hospital General de México Dr. Eduardo Liceaga
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-19
- **Primary completion:** 2024-11-29
- **Final completion:** 2025-02-28
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06318104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06318104, "Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06318104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*